Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases



Comments are closed.

Zebra Medical Vision gets $30M Series C Financing
Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases
Cognition Therapeutics Completes Oversubscribed $12 Million Series B Financing
Eye-Interaction Pioneer Eyefluence Announces Company Launch, Series B Funding